Thomas Ischinger

5.8k total citations · 1 hit paper
61 papers, 3.2k citations indexed

About

Thomas Ischinger is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas Ischinger has authored 61 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 28 papers in Cardiology and Cardiovascular Medicine and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas Ischinger's work include Coronary Interventions and Diagnostics (38 papers), Cerebrovascular and Carotid Artery Diseases (21 papers) and Cardiac Imaging and Diagnostics (17 papers). Thomas Ischinger is often cited by papers focused on Coronary Interventions and Diagnostics (38 papers), Cerebrovascular and Carotid Artery Diseases (21 papers) and Cardiac Imaging and Diagnostics (17 papers). Thomas Ischinger collaborates with scholars based in Germany, United States and Belgium. Thomas Ischinger's co-authors include Bernhard Meier, Andreas R. Gruentzig, John S. Douglas, Jay Hollman, Spencer B. King, Christian W. Hamm, Jacobus Reimers, Hans‐Jürgen Rupprecht, Stephan Windecker and William Wijns and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Thomas Ischinger

61 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

2008 453 citations Stephan Windecker, Patrick W. Serruys et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thomas Ischinger	2.4k	2.2k	1.2k	1.0k	299	61	3.2k
Remo Albiero	3.0k 1.3×	2.1k 0.9×	1.8k 1.5×	1.5k 1.5×	203 0.7×	81	3.6k
Pierre P. Leimgruber	1.6k 0.7×	1.7k 0.8×	944 0.8×	947 0.9×	399 1.3×	23	2.6k
Seong‐Wook Park	3.6k 1.5×	3.2k 1.5×	1.9k 1.7×	1.0k 1.0×	161 0.5×	84	4.5k
Richard R. Heuser	2.6k 1.1×	2.0k 0.9×	1.0k 0.9×	1.2k 1.2×	203 0.7×	114	3.6k
Kazuaki Mitsudo	2.3k 1.0×	1.8k 0.8×	1.2k 1.0×	775 0.8×	190 0.6×	112	2.9k
Gerald Dorros	3.7k 1.6×	2.6k 1.2×	1.5k 1.3×	2.3k 2.3×	353 1.2×	115	5.2k
Eulogio García	1.7k 0.7×	1.8k 0.8×	852 0.7×	620 0.6×	226 0.8×	33	2.6k
Mauro Carlino	3.7k 1.6×	3.2k 1.5×	2.1k 1.9×	1.1k 1.1×	311 1.0×	173	4.5k
Luiz Alberto Mattos	2.4k 1.0×	2.3k 1.0×	1.2k 1.0×	717 0.7×	97 0.3×	154	3.3k
Hongsheng Wu	1.5k 0.6×	944 0.4×	742 0.6×	650 0.6×	73 0.2×	24	2.2k

Countries citing papers authored by Thomas Ischinger

Since Specialization

Citations

This map shows the geographic impact of Thomas Ischinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ischinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ischinger more than expected).

Fields of papers citing papers by Thomas Ischinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ischinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ischinger. The network helps show where Thomas Ischinger may publish in the future.

Co-authorship network of co-authors of Thomas Ischinger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ischinger. A scholar is included among the top collaborators of Thomas Ischinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ischinger. Thomas Ischinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Linke, Axel, Paweł Buszman, Patrick W. Serruys, et al.. (2012). TCT-569 5-year Clinical Outcomes of Biodegradable Polymer Biolimus-eluting Stents versus Durable Polymer Sirolimus-eluting Stents in Patients with and without Diabetes Mellitus: a LEADERS Sub-study. Journal of the American College of Cardiology. 60(17). B165–B166. 1 indexed citations

Serruys, Patrick W., Paweł Buszman, Axel Linke, et al.. (2012). TCT-44 LEADERS: 5-Year Follow-Up from a Prospective, Randomized Trial of Biolimus A9-Eluting Stents with a Biodegradable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer- Final report of the LEADERS study. Journal of the American College of Cardiology. 60(17). B13–B14. 11 indexed citations

Klauß, Volker, Patrick W. Serruys, Thomas Pilgrim, et al.. (2011). 2-Year Clinical Follow-Up From the Randomized Comparison of Biolimus-Eluting Stents With Biodegradable Polymer and Sirolimus-Eluting Stents With Durable Polymer in Routine Clinical Practice. JACC: Cardiovascular Interventions. 4(8). 887–895. 26 indexed citations

Wykrzykowska, Joanna J., Patrick W. Serruys, Paweł Buszman, et al.. (2011). The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS). EuroIntervention. 7(7). 789–795. 36 indexed citations

Leber, Alexander, Markus Kasel, Thomas Ischinger, et al.. (2011). Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system. International Journal of Cardiology. 166(3). 652–657. 70 indexed citations

Wykrzykowska, Joanna J., Scot Garg, Ton de Vries, et al.. (2010). VALUE OF THE SYNTAX SCORE (SX) FOR RISK ASSESSMENT IN THE “ALL-COMERS” POPULATION OF THE RANDOMIZED MULTICENTER LEADERS TRIAL.. Journal of the American College of Cardiology. 55(10). A191.E1787–A191.E1787. 10 indexed citations

Wykrzykowska, Joanna J., Scot Garg, Chrysafios Girasis, et al.. (2010). Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial. Journal of the American College of Cardiology. 56(4). 272–277. 172 indexed citations

Wykrzykowska, Joanna J., Patrick W. Serruys, Yoshinobu Onuma, et al.. (2009). Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer. JACC: Cardiovascular Interventions. 2(9). 861–870. 39 indexed citations

Wykrzykowska, Joanna J., Lorenz Räber, Ton de Vries, et al.. (2009). Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy. EuroIntervention. 5(3). 310–317. 7 indexed citations

10.

Mehta, Rajendra H., Ralf Zahn, Matthias Hochadel, et al.. (2007). Comparison of Inhospital Outcomes of Patients With Versus Without Previous Carotid Endarterectomy Undergoing Carotid Stenting (from the German ALKK CAS Registry). The American Journal of Cardiology. 99(9). 1288–1293. 14 indexed citations

11.

Zahn, Ralf, Thomas Ischinger, Bernd Mark, et al.. (2005). Embolic Protection Devices for Carotid Artery Stenting. Journal of the American College of Cardiology. 45(11). 1769–1774. 45 indexed citations

12.

Ischinger, Thomas, et al.. (2003). Focused force angioplasty. PubMed. 4(1). 47–50. 17 indexed citations

13.

Ischinger, Thomas, et al.. (2003). Improved outcome with novel device for low-pressure PTCA in de novo and in-stent lesions. PubMed. 4(1). 2–6. 11 indexed citations

14.

Ischinger, Thomas, et al.. (2003). Partial malposition of PFO closure device: indication for elective surgical removal?. Zeitschrift für Kardiologie. 92(2). 188–192. 8 indexed citations

15.

Ischinger, Thomas. (2001). Carotid Stenting: Which Stent for Which Lesion?. Journal of Interventional Cardiology. 14(6). 617–623. 8 indexed citations

16.

Hamm, Christian W., P. Kalmár, Jacobus Reimers, et al.. (1996). Clinical outcome and costs of CABG and PTCA in the GABI study over 2 years follow-up. Journal of the American College of Cardiology. 27(2). 55–55. 4 indexed citations

17.

Dartsch, Peter C., Thomas Ischinger, & E. Betz. (1990). Responses of cultured smooth muscle cells from human nonatherosclerotic arteries and primary stenosing lesions after photoradiation: Implications for photodynamic therapy of vascular stenoses. Journal of the American College of Cardiology. 15(7). 1545–1550. 44 indexed citations

18.

Vandormael, Michel, Thomas Ischinger, Ümit T. Aker, et al.. (1985). Immediate and short-term benefit of multilesion coronary angioplasty: Influence of degree of revascularization. Journal of the American College of Cardiology. 6(5). 983–991. 120 indexed citations

19.

Meier, Bernhard, Spencer B. King, Andreas R. Gruentzig, et al.. (1984). Repeat coronary angioplasty. Journal of the American College of Cardiology. 4(3). 463–466. 116 indexed citations

20.

Douglas, John S., Andreas R. Gruentzig, Spencer B. King, et al.. (1983). Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. Journal of the American College of Cardiology. 2(4). 745–754. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact